Breaking News Instant updates and real-time market news.

BILI

Bilibili

$17.39

0.48 (2.84%)

11:45
04/18/19
04/18
11:45
04/18/19
11:45

Bilibili call volume above normal and directionally bullish

Bullish option flow detected in Bilibili with 1,491 calls trading, 1.5x expected, and implied vol increasing almost 2 points to 50.56%. May-19 17.5 calls and Apr-19 17.5 calls are the most active options, with total volume in those strikes near 1,100 contracts. The Put/Call Ratio is 0.29. Earnings are expected on May 23rd.

BILI Bilibili
$17.39

0.48 (2.84%)

02/27/19
02/27/19
INITIATION

Fly Intel: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Algonquin Power (AQN) initiated with a Neutral at BofA/Merrill. 2. Bilibili (BILI) initiated with a Buy at China Renaissance. 3. Livent (LTHM) initiated with a Buy at Gabelli. 4. Champions Oncology (CSBR) initiated with a Buy at National Securities. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/27/19
02/27/19
NO CHANGE

Bilibili reports Q4 EPS (7c), consensus (10c)
Reports Q4 revenue $168.1M, consensus $156.56M.
03/01/19
JPMS
03/01/19
DOWNGRADE
Target $20
JPMS
Neutral
Bilibili downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Alex Yao downgraded Bilibili to Neutral while raising his price target for the shares to $20 from $17. The analyst says that while the company's long-term value continues to rise, near-term expectations are now too high following Bilibili's Q4 results.
04/10/19
UBSW
04/10/19
INITIATION
Target $23
UBSW
Buy
Bilibili initiated with a Buy at UBS
UBS analyst Angela Xu imitated Bilibili with a Buy and $23 price target saying it is uniquely positioned in terms of users and content among online video platforms. Its differentiated content and social features drive a sticky community of anime, comics and games fans and young users, who are highly willing to spend on content, the analyst wrote in a note to investors. Xu believes Bilibili remains in the early stages of monetization and over time has a high chance of developing multiple revenue growth driver than peers.

TODAY'S FREE FLY STORIES

OPI

Office Properties

$32.93

-1.02 (-3.00%)

05:36
12/13/19
12/13
05:36
12/13/19
05:36
Downgrade
Office Properties rating change  »

Office Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOLVY

Volvo

$0.00

(0.00%)

05:36
12/13/19
12/13
05:36
12/13/19
05:36
Hot Stocks
Volvo appoints Scott Rafkin as Chief Digital Officer »

Scott Rafkin, currently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$236.18

2.22 (0.95%)

05:36
12/13/19
12/13
05:36
12/13/19
05:36
Recommendations
Amgen analyst commentary  »

Amgen price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$162.94

-4.5 (-2.69%)

05:36
12/13/19
12/13
05:36
12/13/19
05:36
Upgrade
Nordson rating change  »

Nordson upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$111.41

-1.85 (-1.63%)

05:35
12/13/19
12/13
05:35
12/13/19
05:35
Downgrade
Neurocrine rating change  »

Neurocrine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$162.94

-4.5 (-2.69%)

05:35
12/13/19
12/13
05:35
12/13/19
05:35
Downgrade
Nordson rating change  »

Nordson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPG

Galapagos

$214.12

-0.74 (-0.34%)

05:33
12/13/19
12/13
05:33
12/13/19
05:33
Downgrade
Galapagos rating change  »

Galapagos downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GILD

Gilead

$67.64

0.5 (0.74%)

05:31
12/13/19
12/13
05:31
12/13/19
05:31
Downgrade
Gilead rating change  »

Gilead downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$293.92

1.71 (0.59%)

05:29
12/13/19
12/13
05:29
12/13/19
05:29
Upgrade
Biogen rating change  »

Biogen upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$372.10

-1.41 (-0.38%)

05:26
12/13/19
12/13
05:26
12/13/19
05:26
Upgrade
Regeneron rating change  »

Regeneron upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

, EXEL

Exelixis

$17.68

0.05 (0.28%)

05:25
12/13/19
12/13
05:25
12/13/19
05:25
Hot Stocks
Genentech says Phase III IMspire150 study met primary endpoint of PFS »

Genentech, a member of…

RHHBY

Roche

$0.00

(0.00%)

EXEL

Exelixis

$17.68

0.05 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

HTHT

Huazhu Group

$34.86

0.92 (2.71%)

05:23
12/13/19
12/13
05:23
12/13/19
05:23
Upgrade
Huazhu Group rating change  »

Huazhu Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

05:22
12/13/19
12/13
05:22
12/13/19
05:22
Hot Stocks
Genentech says Phase III IMspire150 study met primary endpoint of PFS »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

SNAP

Snap

$14.45

0.22 (1.55%)

05:19
12/13/19
12/13
05:19
12/13/19
05:19
Upgrade
Snap upgraded to Outperform from Market Perform at JMP Securities »

JMP Securities analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$92.79

-2.2 (-2.32%)

05:16
12/13/19
12/13
05:16
12/13/19
05:16
Recommendations
Incyte analyst commentary  »

Incyte risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

PCG

PG&E

$11.75

-0.38 (-3.13%)

05:14
12/13/19
12/13
05:14
12/13/19
05:14
Hot Stocks
PG&E files amended plan of reorganization »

PG&E Corporation and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

05:12
12/13/19
12/13
05:12
12/13/19
05:12
Recommendations
Sarepta price target raised to $210 from $185 at Piper Jaffray »

Piper Jaffray analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOVE

Lovesac

$11.81

-2.68 (-18.50%)

05:07
12/13/19
12/13
05:07
12/13/19
05:07
Downgrade
Lovesac rating change  »

Lovesac downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 19

    Dec

TDOC

Teladoc

$77.06

-0.36 (-0.46%)

05:04
12/13/19
12/13
05:04
12/13/19
05:04
Initiation
Teladoc initiated  »

Teladoc initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTMI

TTM Technologies

$13.79

0.19 (1.40%)

05:01
12/13/19
12/13
05:01
12/13/19
05:01
Upgrade
TTM Technologies rating change  »

TTM Technologies upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FII

Federated Investors

$34.41

0.41 (1.21%)

05:01
12/13/19
12/13
05:01
12/13/19
05:01
Downgrade
Federated Investors rating change  »

Federated Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMK

AssetMark Financial

$27.31

0.42 (1.56%)

05:00
12/13/19
12/13
05:00
12/13/19
05:00
Upgrade
AssetMark Financial rating change  »

AssetMark Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCTR

Victory Capital

$21.68

0.235 (1.10%)

05:00
12/13/19
12/13
05:00
12/13/19
05:00
Downgrade
Victory Capital rating change  »

Victory Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EV

Eaton Vance

$47.08

0.395 (0.85%)

05:00
12/13/19
12/13
05:00
12/13/19
05:00
Upgrade
Eaton Vance rating change  »

Eaton Vance upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$60.47

-0.37 (-0.61%)

04:59
12/13/19
12/13
04:59
12/13/19
04:59
Initiation
Papa John's initiated  »

Papa John's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.